The weekly litigation news digest is live. Subscribe now

Oral Formulations Of Deferasirox - EP2964202

The patent EP2964202 was granted to Novartis on May 31, 2023. The application was originally filed on Mar 6, 2014 under application number EP14710654A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2964202

NOVARTIS
Application Number
EP14710654A
Filing Date
Mar 6, 2014
Status
Patent Maintained As Amended
Apr 28, 2023
Publication Date
May 31, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

INVOKAT SERVICESJul 31, 2019MUTLUADMISSIBLE
HGFJul 30, 2019HGFADMISSIBLE
TEVA PHARMACEUTICALSJul 23, 2019ELKINGTON AND FIFEADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2005097062
INTERNATIONAL-SEARCH-REPORTWO2009130604
INTERNATIONAL-SEARCH-REPORTWO2010143006
INTERNATIONAL-SEARCH-REPORTWO9749395
OPPOSITIONEP2964202
OPPOSITIONEP3124018
OPPOSITIONUS2011097413
OPPOSITIONWO2004035026
OPPOSITIONWO2005097062
OPPOSITIONWO2007045445
OPPOSITIONWO2009067557
OPPOSITIONWO2009106824
OPPOSITIONWO2010035282
OPPOSITIONWO2010143006
OPPOSITIONWO2012042224
OPPOSITIONWO2014136079
OPPOSITIONWO2017158559

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents